keyword
https://read.qxmd.com/read/38619212/combining-mhealth-technology-and-pharmacotherapy-to-improve-mental-health-outcomes-and-reduce-human-rights-abuses-in-west-africa-intervention-field-trial
#1
JOURNAL ARTICLE
Dror Ben-Zeev, Anna Larsen, Dzifa A Attah, Kwadwo Obeng, Alexa Beaulieu, Seth M Asafo, Jonathan Kuma Gavi, Arya Kadakia, Emmanuel Quame Sottie, Sammy Ohene, Lola Kola, Kevin Hallgren, Jaime Snyder, Pamela Y Collins, Angela Ofori-Atta
BACKGROUND: In West Africa, healers greatly outnumber trained mental health professionals. People with serious mental illness (SMI) are often seen by healers in "prayer camps" where they may also experience human rights abuses. We developed "M&M," an 8-week-long dual-pronged intervention involving (1) a smartphone-delivered toolkit designed to expose healers to brief psychosocial interventions and encourage them to preserve human rights (M-Healer app), and (2) a visiting nurse who provides medications to their patients (Mobile Nurse)...
March 27, 2024: JMIR Mental Health
https://read.qxmd.com/read/38610948/assessing-trifecta-and-pentafecta-success-rates-between-robot-assisted-vs-open-radical-cystectomy-a-propensity-score-matched-analysis
#2
JOURNAL ARTICLE
Filippo Gavi, Nazario Foschi, Daniele Fettucciari, Pierluigi Russo, Diana Giannarelli, Mauro Ragonese, Carlo Gandi, Giovanni Balocchi, Alessandra Francocci, Francesco Pio Bizzarri, Filippo Marino, Giovanni Battista Filomena, Giuseppe Palermo, Angelo Totaro, Marco Racioppi, Riccardo Bientinesi, Emilio Sacco
BACKGROUND: This study aimed to evaluate the surgical and oncological outcomes of robot-assisted radical cystectomy (RARC) versus open radical cystectomy (ORC) using trifecta and pentafecta parameters. METHODS: The clinical data of 41 patients who underwent RARC between 2018 and 2022 were prospectively collected and retrospectively compared to those of 330 patients undergoing ORC using 1:1 propensity score matching. Trifecta was defined as simultaneous negative surgical margins (SMs), a lymph node (LN) yield ≥ 16, and the absence of major complications (Clavien-Dindo grade III-V) within 90 days postoperatively...
March 25, 2024: Cancers
https://read.qxmd.com/read/38583454/feasibility-safety-and-impact-of-the-rts-s-as01-e-malaria-vaccine-when-implemented-through-national-immunisation-programmes-evaluation-of-cluster-randomised-introduction-of-the-vaccine-in-ghana-kenya-and-malawi
#3
JOURNAL ARTICLE
Kwaku Poku Asante, Don P Mathanga, Paul Milligan, Samuel Akech, Abraham Oduro, Victor Mwapasa, Kerryn A Moore, Titus K Kwambai, Mary J Hamel, Thomas Gyan, Nelli Westercamp, Atupele Kapito-Tembo, Patricia Njuguna, Daniel Ansong, Simon Kariuki, Tisungane Mvalo, Paul Snell, David Schellenberg, Paul Welega, Lucas Otieno, Alfred Chimala, Edwin A Afari, Philip Bejon, Kenneth Maleta, Tsiri Agbenyega, Robert W Snow, Madaliso Zulu, Jobiba Chinkhumba, Aaron M Samuels
BACKGROUND: The RTS,S/AS01E malaria vaccine (RTS,S) was introduced by national immunisation programmes in Ghana, Kenya, and Malawi in 2019 in large-scale pilot schemes. We aimed to address questions about feasibility and impact, and to assess safety signals that had been observed in the phase 3 trial that included an excess of meningitis and cerebral malaria cases in RTS,S recipients, and the possibility of an excess of deaths among girls who received RTS,S than in controls, to inform decisions about wider use...
April 4, 2024: Lancet
https://read.qxmd.com/read/38565994/an-evaluation-of-the-cost-of-human-papilloma-virus-hpv-vaccine-delivery-in-zambia
#4
JOURNAL ARTICLE
Moses C Simuyemba, Chitalu M Chama-Chiliba, Abson Chompolola, Aaron Sinyangwe, Abdallah Bchir, Gilbert Asiimwe, Carla Chibwesha, Felix Masiye
BACKGROUND: Human papillomavirus (HPV) is a common sexually transmitted infection and the leading cause of cervical cancer. The HPV vaccine is a safe and effective way to prevent HPV infection. In Zambia, the vaccine is given during Child Health Week to girls aged 14 years who are in and out of school in two doses over two years. The focus of this evaluation was to establish the cost to administer a single dose of the vaccine as well as for full immunisation of two doses. METHODS: This work was part of a broader study on assessing HPV programme implementation in Zambia...
April 2, 2024: BMC Infectious Diseases
https://read.qxmd.com/read/38515600/health-transformation-toward-universal-healthcare-coverage-amidst-conflict-examining-the-impact-of-international-cooperation-in-niger
#5
Mahamadou Doutchi, Abdoulaye Ghousmane, Fatimata Zampaligre, Bizo Moussa, El Khalef Ishagh, Ouédraogo Talatou Marc, Batouré Oumarou, Mutenda Sheria Kaya, Gbaguidi Aichatou Diawara, Abdoulaye Macire Camara, Seyni Moussa, Kuyangisa Bienvenu, Joseph Toko, Hamidou Harouna, Haladou Moussa, N'Zue Kofi, Jacques Lukenze Tamuzi, Patrick D M C Katoto, Charles S Wiysonge, Blanche-Philomene Melanga Anya
BACKGROUND: Approximately 70% of Sub-Saharan African countries have experienced armed conflicts with significant battle-related fatalities in the past two decades. Niger has witnessed a substantial rise in conflict-affected populations in recent years. In response, international cooperation has aimed to support health transformation in Niger's conflict zones and other conflict-affected areas in Sub-Saharan Africa. This study seeks to review the available evidence on health interventions facilitated by international cooperation in conflict zones, with a focus on Niger...
2024: Frontiers in Public Health
https://read.qxmd.com/read/38491894/changing-roles-in-global-health-governance-following-covid-19
#6
JOURNAL ARTICLE
Wafa Abu El Kheir-Mataria, Hassan El-Fawal, Sungsoo Chun
BACKGROUND: The Global Health Governance (GHG) response to the COVID-19 pandemic has been criticized, particularly regarding vaccine management, and changes in the roles of GHG actors have been recommended. AIM: To investigate the perception of experts regarding changes in the roles of different GHG actors following the COVID-19 pandemic. METHODS: This study used a 3-round Delphi survey to collect data from 30 global health experts between May and December 2022...
February 25, 2024: Eastern Mediterranean Health Journal
https://read.qxmd.com/read/38485425/estimating-the-health-effects-of-covid-19-related-immunisation-disruptions-in-112-countries-during-2020-30-a-modelling-study
#7
JOURNAL ARTICLE
Anna-Maria Hartner, Xiang Li, Susy Echeverria-Londono, Jeremy Roth, Kaja Abbas, Megan Auzenbergs, Margaret J de Villiers, Matthew J Ferrari, Keith Fraser, Han Fu, Timothy Hallett, Wes Hinsley, Mark Jit, Andromachi Karachaliou, Sean M Moore, Shevanthi Nayagam, Timos Papadopoulos, T Alex Perkins, Allison Portnoy, Quan Tran Minh, Emilia Vynnycky, Amy K Winter, Holly Burrows, Cynthia Chen, Hannah E Clapham, Aniruddha Deshpande, Sarah Hauryski, John Huber, Kevin Jean, Chaelin Kim, Jong-Hoon Kim, Jemima Koh, Benjamin A Lopman, Virginia E Pitzer, Yvonne Tam, Philipp Lambach, So Yoon Sim, Kim Woodruff, Neil M Ferguson, Caroline L Trotter, Katy A M Gaythorpe
BACKGROUND: There have been declines in global immunisation coverage due to the COVID-19 pandemic. Recovery has begun but is geographically variable. This disruption has led to under-immunised cohorts and interrupted progress in reducing vaccine-preventable disease burden. There have, so far, been few studies of the effects of coverage disruption on vaccine effects. We aimed to quantify the effects of vaccine-coverage disruption on routine and campaign immunisation services, identify cohorts and regions that could particularly benefit from catch-up activities, and establish if losses in effect could be recovered...
April 2024: Lancet Global Health
https://read.qxmd.com/read/38448324/landscaping-analysis-of-immunization-progress-and-program-structures-in-selected-middle-income-southeast-asian-countries
#8
JOURNAL ARTICLE
Jessabelle E Basa, Ralf Clemens, Sue Ann Costa Clemens, Martin Nicholson
This study examined the performance and structures of national immunization program in five middle-income Southeast Asian countries - Malaysia, Thailand, Philippines, Viet Nam, and Myanmar, and analyzed how the different structures relate to the difference in program performance to identify effective strategies in the study countries that facilitated good immunization performance. Data were derived from published literature, and WHO/UNICEF/Gavi databases, with 2010 as the baseline year. UMICs Malaysia and Thailand maintained ≥90 % coverage from 2010 to 2020 and even during the COVID-19 pandemic in 2021...
March 5, 2024: Vaccine
https://read.qxmd.com/read/38430916/integration-of-the-rts-s-as01-malaria-vaccine-into-the-essential-programme-on-immunisation-in-western-kenya-a-qualitative-longitudinal-study-from-the-health-system-perspective
#9
JOURNAL ARTICLE
Jenny Hill, Teresa Bange, Jenna Hoyt, Simon Kariuki, Mohamed F Jalloh, Jayne Webster, George Okello
BACKGROUND: Malaria accounts for over half a million child deaths annually. WHO recommends RTS,S/AS01 to prevent malaria in children living in moderate-to-high malaria transmission regions. We conducted a qualitative longitudinal study to investigate the contextual and dynamic factors shaping vaccine delivery and uptake during a pilot introduction in western Kenya. METHODS: The study was conducted between Oct 3, 2019, and Mar 24, 2022. We conducted participant and non-participant observations and in-depth interviews with health-care providers, health managers, and national policymakers at three timepoints using an iterative approach and observations of practices and processes of malaria vaccine delivery...
February 28, 2024: Lancet Global Health
https://read.qxmd.com/read/38400137/assessing-vaccination-delivery-strategies-for-zero-dose-and-under-immunized-children-in-the-fragile-context-of-somalia
#10
JOURNAL ARTICLE
Ahmed Said Bile, Mohamed A Ali-Salad, Amina J Mahmoud, Neha S Singh, Nada Abdelmagid, Majdi M Sabahelzain, Francesco Checchi, Sandra Mounier-Jack, Barni Nor
Somalia is one of 20 countries in the world with the highest numbers of zero-dose children. This study aims to identify who and where zero-dose and under-vaccinated children are and what the existing vaccine delivery strategies to reach zero-dose children in Somalia are. This qualitative study was conducted in three geographically diverse regions of Somalia (rural/remote, nomadic/pastoralists, IDPs, and urban poor population), with government officials and NGO staff ( n = 17), and with vaccinators and community members ( n = 52)...
February 1, 2024: Vaccines
https://read.qxmd.com/read/38372240/efficacy-of-transurethral-botulinum-toxin-a-injections-for-bladder-outlet-obstruction-a-systematic-review-and-meta-analysis
#11
REVIEW
Filippo Gavi, Mauro Ragonese, Daniele Fettucciari, Riccardo Bientinesi, Carlo Gandi, Marco Campetella, Filippo Marino, Marco Racioppi, Emilio Sacco, Nazario Foschi
INTRODUCTION: Botulinum toxin A (BoNT-A) injections in the prostate gland have been used as a minimally invasive option for treating bladder outlet obstruction (BOO). However, the efficacy of transurethral BoNT-A injections for BOO is not well established in the literature. The aim of this study is to collect evidence on the efficacy of transurethral BoNT-A injections for the treatment of BOO. MATERIALS AND METHODS: This systematic review and meta-analyses was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) statement...
February 19, 2024: Urologia
https://read.qxmd.com/read/38335976/immunological-response-to-fractional-dose-yellow-fever-vaccine-administered-during-an-outbreak-in-kinshasa-democratic-republic-of-the-congo-results-5-years-after-vaccination-from-a-prospective-cohort-study
#12
JOURNAL ARTICLE
Reena H Doshi, Patrick K Mukadi, Rebecca M Casey, Gabriel M Kizito, Hongjiang Gao, Beatrice Nguete U, Janeen Laven, Lilliane Sabi, Didine K Kaba, Jean-Jacques Muyembe-Tamfum, Terri B Hyde, Steve Ahuka-Mundeke, J Erin Staples
BACKGROUND: In 2016, outbreaks of yellow fever in Angola and the Democratic Republic of the Congo led to a global vaccine shortage. A fractional dose of 17DD yellow fever vaccine (containing one-fifth [0·1 ml] of the standard dose) was used during a pre-emptive mass campaign in August, 2016, in Kinshasa, Democratic Republic of the Congo among children aged 2 years and older and non-pregnant adults (ie, those aged 18 years and older). 1 year following vaccination, 97% of participants were seropositive; however, the long-term durability of the immune response is unknown...
February 6, 2024: Lancet Infectious Diseases
https://read.qxmd.com/read/38234993/a-cross-sectional-assessment-of-the-effects-of-select-training-modalities-on-vaccine-cold-chain-management
#13
JOURNAL ARTICLE
Aguma Daniel, Joseph Oloro, Innocent Hahirwa, Theogene Rizinde, Marie Francoise Mukanyangezi
BACKGROUND: Vaccines offer arguably the most cost-effective public health intervention. Vaccine supply chain management which is a critical building block faces many Human resources challenges mainly due to the special attributes of vaccines. OBJECTIVE: This study attempted to measure the effect of training on vaccine cold chain handler knowledge and practices. METHODS: A cross-sectional research design, using predominantly quantitative data collection techniques, was used...
2024: Journal of Pharmaceutical Policy and Practice
https://read.qxmd.com/read/38216207/is-health-expenditure-on-immunisation-associated-with-immunisation-coverage-in-sub-saharan-africa-a-multicountry-analysis-2013-2017
#14
JOURNAL ARTICLE
Israel Oluwaseyidayo Idris, Luke Ouma, Janet Tapkigen, Francis Ifeanyi Ayomoh, Gabriel Omoniyi Ayeni
OBJECTIVES: The designing of contextually tailored sustainable plans to finance the procurement of vaccines and the running of appropriate immunisation programmes are necessary to address the high burden of vaccine-preventable diseases and low immunisation coverage in sub-Saharan Africa (SSA). We sought to estimate the minimum fraction of a country's health budget that should be invested in national immunisation programmes to achieve national immunisation coverage of 80% or greater depending on the context, with and without donors' support...
January 12, 2024: BMJ Open
https://read.qxmd.com/read/38140245/first-field-test-of-the-novel-integration-mapping-tool-for-covid-19-vaccination-integration-into-national-immunization-programs-and-primary-healthcare-a-case-study-from-c%C3%A3-te-d-ivoire
#15
JOURNAL ARTICLE
Adidja Amani, Ekra Kouadio Daniel, Brou Gbotto, Kossia Yao, Aka Lépri Nicaise, Epa Kouakou, Kouadio Sie Kabran, Gervais Gahongano, Abdoul Gadiry Fadiga, Abdou Aziz Gbaya, Oniovo Efe-Aluta, Franck Mboussou, Imran Mirza, Benjamin Schreiber
INTRODUCTION: With the containment of the COVID-19 pandemic in Côte d'Ivoire, efforts were made to seamlessly integrate COVID-19 vaccination into the national immunization program. A collaborative initiative involving UNICEF, WHO, GAVI, and partner organizations resulted in the creation of the COVID-19 Vaccine Integration Mapping Tool. This paper presents a case study documenting the field testing of the integration mapping tool and assessing the integration of COVID-19 vaccination within primary healthcare and routine immunization in Côte d'Ivoire...
December 12, 2023: Vaccines
https://read.qxmd.com/read/38062606/commodifying-vaccines-to-curtail-antibiotic-resistance-impact-in-malaria-endemic-countries
#16
JOURNAL ARTICLE
Maria Khan
Rampant and prevalent deployment of an efficient malaria vaccine in Pakistan, together with basic control and preventive measures, could significantly decrease the economic and healthcare burden caused by drug-resistant malaria. Moreover, RTS, S/AS01 vaccine has attained a much-needed breakthrough after decades of growth, as an innovative vaccine for malaria in Phase III clinical trials, and presently undergoing implementation studies. So far Gavi, WHO, and other stakeholders are contemplating on the practical issues, risk-benefit, and cost-effectiveness in resource-limited settings of vaccine implementation capacity...
December 2023: Journal of the College of Physicians and Surgeons—Pakistan: JCPSP
https://read.qxmd.com/read/38006054/new-vaccine-introductions-in-who-african-region-between-2000-and-2022
#17
JOURNAL ARTICLE
Chinwe Iwu-Jaja, Chidozie Declan Iwu, Anelisa Jaca, Charles Shey Wiysonge
Significant progress has been made in vaccine development worldwide. This study examined the WHO African Region's vaccine introduction trends from 2000 to 2022, excluding COVID-19 vaccines. We extracted data on vaccine introductions from the WHO/UNICEF joint reporting form for 17 vaccines. We examined the frequency and percentages of vaccine introductions from 2000 to 2022, as well as between two specific time periods (2000-2010 and 2011-2022). We analysed Gavi eligible and ineligible countries separately and used a Chi-squared test to determine if vaccine introductions differed significantly...
November 16, 2023: Vaccines
https://read.qxmd.com/read/37793808/a-critical-analysis-of-covax-alliance-and-corresponding-global-health-governance-and-policy-issues-a-scoping-review
#18
JOURNAL ARTICLE
Anjali Pushkaran, Vijay Kumar Chattu, Prakash Narayanan
INTRODUCTION: The COVAX alliance is a novel approach to international partnership in global health intended to achieve the worthy goal of 'COVID-19 vaccine equity'. This study aimed to identify the implementation challenges and framework gaps of COVAX and to explore the interconnected global health policy and governance gaps in ensuring equity, accessibility and affordability of vaccines. METHODS: A scoping review was conducted to identify the implementation challenges and framework gaps of COVAX and related global health policy and governance gaps...
October 2023: BMJ Global Health
https://read.qxmd.com/read/37505666/seroprevalence-and-genotype-diversity-of-hepatitis-c-virus-in-the-caribbean-a-review
#19
REVIEW
Michelle G Brown, John F Lindo, Ivan E Vickers, Kereann Nelson, Yakima Phillips, Cameil Wilson-Clarke, Samuel Gavi, Gene D Morse, Andrew H Talal
Hepatitis C (HCV) continues to present a global public health challenge, with no vaccine available for prevention. Despite the availability of direct-acting antivirals (DAAs) to cure HCV, it remains prevalent in many regions including the Caribbean. As efforts are made to eliminate HCV from the region, existing barriers, such as the high cost of DAAs and lack of an established database of HCV cases within the Caribbean, must be addressed. This review seeks to assess epidemiologic trends (seroprevalence and genotypic diversity) of HCV in the Caribbean and identify gaps in surveillance of the disease...
July 17, 2023: Tropical Medicine and Infectious Disease
https://read.qxmd.com/read/37474227/health-effects-of-routine-measles-vaccination-and-supplementary-immunisation-activities-in-14-high-burden-countries-a-dynamic-measles-immunization-calculation-engine-dynamice-modelling-study
#20
JOURNAL ARTICLE
Megan Auzenbergs, Han Fu, Kaja Abbas, Simon R Procter, Felicity T Cutts, Mark Jit
BACKGROUND: WHO recommends at least 95% population coverage with two doses of measles-containing vaccine (MCV). Most countries worldwide use routine services to offer a first dose of measles-containing vaccine (MCV1) and later, a second dose of measles-containing vaccine (MCV2). Many countries worldwide conduct supplementary immunisation activities (SIAs), offering vaccination to all people in a specific age range irrespective of previous vaccination history. We aimed to estimate the relative effects of each dose and delivery route in 14 countries with high measles burden...
August 2023: Lancet Global Health
keyword
keyword
19471
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.